Company intelligence / Profile preview

Wuhan YZY Medical Science and Technology

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Wuhan YZY Medical Science and Technology has developed over 160 genetic diagnostic products and multiple IVD devices since 2014. Fourteen molecular diagnostic kits have obtained Class III medical device registration certificates from the National Medical Products Administration (NMPA), with more than 110 products CE certified. Their platforms support precision medicine in cardiovascular, cerebrovascular, and oncology fields by enabling personalized diagnostics.

Therapeutic areas: OncologyCardiovascular
Modalities: Diagnostic deviceMolecular diagnostic kitIn vitro diagnostic device
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Wuhan YZY Medical Science and Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan YZY Medical Science and Technology.

Explore the full profile